NY Times
JULY 14, 2021
The company said it had determined that daily exposure to five Neutrogena and Aveeno sprays would not cause adverse health effects, but recalled the products out of an abundance of caution.
Pharma Times
JULY 13, 2021
In 2020, the two partners announced an initial collaboration to integrate Cegedim’s ‘THIN’ European real-world data into Aetion’s evidence platform
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JULY 14, 2021
The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.
pharmaphorum
JULY 13, 2021
Faced with a looming mental health crisis, the UK government has been urged to invest in the digitisation of service provision across the NHS in England in a new report from think tank Future Care Capital. The study’s author – FCC’s head of policy and research Dr Peter Bloomfield, argues that there has been a lack of support for mental health services for many years in the UK, and the pathways for accessing them are “convoluted, waiting lists are extensive, and outcomes are po
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
JULY 16, 2021
Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. We’ll be sharing our expertise and best practices for strategic…. The post DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
JULY 13, 2021
Researchers discover presence of 'autoantibodies' in people with persistent COVID-19 symptoms
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
JULY 15, 2021
The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The Competition and Markets Authority (CMA) took the action against Auden Mckenzie and Actavis UK – now known as Accord-UK – and other companies after an investigation into the price of hydrocortisone tablets, which rose by 10,000% over a 10-year period.
NY Times
JULY 12, 2021
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Pharma Times
JULY 12, 2021
Vaccine effectiveness against symptomatic disease in at-risk groups is approximately 60% after one dose of either the AZ or Pfizer/BioNTech vaccines
Outsourcing Pharma
JULY 15, 2021
Eli Lilly and Company and Banner Alzheimerâs Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional decline related to Alzheimerâs disease.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JULY 14, 2021
AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in some people receiving the jabs. At the same time, the UK’s National Institute for Health and Care excellence (NICE) is developing guidance to help doctors manage the cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) and low blood platelet counts that have been seen with the COVID-19 va
NY Times
JULY 12, 2021
After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.
Pharma Times
JULY 12, 2021
NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources
Outsourcing Pharma
JULY 14, 2021
A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.
pharmaphorum
JULY 14, 2021
In this episode of Health Innovators , pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic research at UK company Adaptimmune which is transforming cancer immunotherapy with affinity enhanced T-cell receptors. Adaptimmune’s SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
NY Times
JULY 14, 2021
The rejection of the new Alzheimer’s drug by the two major medical centers is one of the starkest signs of concern over its approval by the F.D.A.
Pharma Times
JULY 12, 2021
BMA research finds the number of doctors per 1,000 people in England is 25 years behind comparable EU nations
Outsourcing Pharma
JULY 13, 2021
The genetic exome sequence analysis partnership has created a large database linking rare protein-coding genetic variants to human health and disease.
pharmaphorum
JULY 13, 2021
Diagnosing Alzheimer’s disease is still a challenge, particularly in its earliest stages, but a new study suggests that subtle changes in behaviour whilst driving could serve as an early warning system. The researchers used GPS logging devices and machine learning as “digital biomarkers” to compare the driving of people who have preclinical Alzheimer’s but are still cognitively normal to a control group of normal age-matched drivers over the course of a year.
NY Times
JULY 12, 2021
Although studies of a third dose are underway, experts agree that the vaccines are still working well, even against the Delta variant, and that booster shots are not necessary right now.
Pharma Times
JULY 12, 2021
Data also suggested filgotinib 200mg reduced and eliminated corticosteroid use compared to placebo
Outsourcing Pharma
JULY 14, 2021
A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data management.
pharmaphorum
JULY 14, 2021
James Dempsey breaks down the misconception that culture can’t be measured, and gives tips for how companies can implement a clear culture strategy. In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.
Pharma Marketing Network
JULY 16, 2021
Hear from leading Experience and Omnichannel experts from Merck , AstraZeneca , UCB , AbbVie , Harmony Biosciences , Genentech and more on winning strategies to transform data into actionable strategy, elevate CX beyond campaign optimization and activate the “Engagement Matrix” in your organization. Panel discussions include: Coordinated CX: Moving Beyond Campaign Management.
Pharma Times
JULY 15, 2021
At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772
Outsourcing Pharma
JULY 15, 2021
The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.
pharmaphorum
JULY 12, 2021
A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their blood. . Researchers at Imperial College London (ICL) led by Professor Danny Altmann told the BBC’s Panorama programme that they have identified a pattern of antibodies in people with long COVID different from those who have fully recovered from COVID-19.
Drug Patent Watch
JULY 16, 2021
Annual Drug Patent Expirations for XPOVIO Xpovio is a drug marketed by Karyopharm Theraps and is included in one NDA. There are five patents protecting this drug. This drug has…. The post New patent for Karyopharm Theraps drug XPOVIO appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
JULY 15, 2021
The positive opinion has been issued via the MHRA’s early access the medicine (EAMS) scheme
Pharma Marketing Network
JULY 16, 2021
Hear from leading Experience and Omnichannel experts from Merck , AstraZeneca , UCB , AbbVie , Harmony Biosciences , Genentech and more on winning strategies to transform data into actionable strategy, elevate CX beyond campaign optimization and activate the “Engagement Matrix” in your organization. Panel discussions include: Coordinated CX: Moving Beyond Campaign Management.
pharmaphorum
JULY 14, 2021
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only become activated when needed.
Drug Patent Watch
JULY 16, 2021
Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme, Schering, and Msd Merck Co and, and is included in four NDAs. It is available…. The post New patent for Merck Sharp drug NOXAFIL appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
JULY 14, 2021
Funding will go towards a number of measures aimed at speeding up cancer diagnosis and treatment
Pharma Marketing Network
JULY 16, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: PMN 2021 Summer Summit: Evolving the Customer Experience appeared first on Pharma Marketing Network.
pharmaphorum
JULY 15, 2021
An experimental artificial heart developed by French medical device specialist CARMAT has been implanted into the first of 10 subjects due to be enrolled in a US trial. The Aeson bioprosthetic device has already been implanted in a number of European patients with end-stage biventricular heart failure – affecting both sides of the heart – and shown that it can keep them alive for months, even after they have been sent home for hospital.
Expert insights. Personalized for you.
144 
Let's personalize your content